The European Cancer Prevention Organization

How should we manage patients with acute lymphoblastic leukaemia during COVID-19?

Why the ADAURA study is a big step forward for NSCLC

Lung cancer updates from ASCO 2020

Who does the work in cancer control?

Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab

Renal cell cancer: Highlights from ASCO 2020

Long-term disease control in multiple myeloma by in-class transitioning: A community-based study

Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma

Treating acute lymphoblastic leukaemia in the era of COVID-19

Managing acute myeloid leukaemia during the COVID-19 pandemic

Meet the Expert: Daniel Seymour